{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:53:32Z","timestamp":1790470412442,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"International atherosclerosis society (2017)"},{"DOI":"10.13039\/100009377","name":"Educational Department of Hunan Province Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["16B228"],"award-info":[{"award-number":["16B228"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Province Postgraduate Research and Innovation Project","award":["CX2017B549"],"award-info":[{"award-number":["CX2017B549"]}]},{"name":"Undergraduate Training Programs for Innovation and Entrepreneurship","award":["20161055500"],"award-info":[{"award-number":["20161055500"]}]},{"name":"Undergraduate Training Programs for Innovation and Entrepreneurship","award":["2016-283-309"],"award-info":[{"award-number":["2016-283-309"]}]},{"name":"Construct Program of the Basic Medicine Key Discipline in Hunan Province"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.atherosclerosis.2017.11.033","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T20:03:12Z","timestamp":1512158592000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["TM6SF2: A novel target for plasma lipid regulation"],"prefix":"10.1016","volume":"268","author":[{"given":"Ting-Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang-Heng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Han","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2017.11.033_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000056784","article-title":"Cloning of the novel gene TM6SF1 reveals conservation of clusters of paralogous genes between human chromosomes 15q24-->q26 and 19p13.3-->p12","volume":"90","author":"Carim-Todd","year":"2000","journal-title":"Cytogenet Cell Genet."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2017.11.033_bib2","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2017.11.033_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fgene.2014.00439","article-title":"TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease","volume":"5","author":"Sanchez-Pulido","year":"2014","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.11.033_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.11.033_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.2926","article-title":"Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk","volume":"46","author":"Holmen","year":"2014","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2017.11.033_bib6","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a Gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","author":"Smagris","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.11.033_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/hep.29021","article-title":"TM6SF2 rs58542926 impacts lipid processing in liver and small intestine","volume":"65","author":"O'Hare","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.27556","article-title":"Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity","volume":"61","author":"Sookoian","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","article-title":"Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans","volume":"40","author":"Kathiresan","year":"2008","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.269","article-title":"Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts","volume":"41","author":"Aulchenko","year":"2009","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat. Genet."},{"issue":"7307","key":"10.1016\/j.atherosclerosis.2017.11.033_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.11.033_bib15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Global Lipids Genetics","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2017.11.033_bib16","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib17","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jhep.2015.01.040","article-title":"The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese","volume":"62","author":"Wang","year":"2015","journal-title":"J.\u00a0Hepatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.28283","article-title":"Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: a multiethnic study","volume":"63","author":"Goffredo","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.033_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2014.04.047","article-title":"Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese","volume":"61","author":"Wong","year":"2014","journal-title":"J.\u00a0Hepatol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.11.033_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/pr.2016.3","article-title":"Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC study","volume":"79","author":"Viitasalo","year":"2016","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ijpo.12032","article-title":"TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children","volume":"11","author":"Grandone","year":"2016","journal-title":"Pediatr. Obes."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.11.033_bib22","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/hmg\/ddx159","article-title":"Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis","volume":"26","author":"Ehrhardt","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2015.08.027","article-title":"HDL: quality or quantity?","volume":"243","author":"Santos-Gallego","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.033_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11883-011-0177-0","article-title":"Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux","volume":"13","author":"Santos-Gallego","year":"2011","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.033_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2014.10.010","article-title":"Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2","volume":"62","author":"Zhou","year":"2015","journal-title":"J.\u00a0Hepatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hep.28475","article-title":"Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes","volume":"64","author":"Eslam","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib27","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial","volume":"63","author":"Scorletti","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.atherosclerosis.2017.11.033_bib28","doi-asserted-by":"crossref","first-page":"27718","DOI":"10.1038\/srep27718","article-title":"Meta-analysis of the influence of TM6SF2 E167K variant on plasma concentration of aminotransferases across different populations and diverse liver phenotypes","volume":"6","author":"Sookoian","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1194\/jlr.P067454","article-title":"Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study","volume":"58","author":"Krawczyk","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib30","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","article-title":"The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis","volume":"62","author":"Pirola","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-015-0554-1","article-title":"HDL Cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target","volume":"18","author":"Bhatt","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2017.11.033_bib32","doi-asserted-by":"crossref","first-page":"23870","DOI":"10.1038\/srep23870","article-title":"Prevalence and risk factors of carotid plaque among middle-aged and elderly adults in rural Tianjin, China","volume":"6","author":"Zhan","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.11.033_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1212\/WNL.0000000000001202","article-title":"Lipid and lipoprotein measurements and the risk of ischemic vascular events: framingham Study","volume":"84","author":"Pikula","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.atherosclerosis.2012.05.011","article-title":"Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol","volume":"223","author":"Kim","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib35","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","article-title":"High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy","volume":"168","author":"Koenig","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.033_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/cvr\/cvp249","article-title":"C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction","volume":"84","author":"Devaraj","year":"2009","journal-title":"Cardiovasc Res."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.11.033_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.104.489260","article-title":"C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the strong heart study","volume":"112","author":"Best","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.CIR.100.1.96","article-title":"C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?","volume":"100","author":"Lagrand","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.033_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/heartjnl-2011-300747","article-title":"Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review","volume":"98","author":"Peters","year":"2012","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"40 Suppl","key":"10.1016\/j.atherosclerosis.2017.11.033_bib41","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"1","author":"Clark","year":"2006","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.11.033_bib42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","article-title":"From fat to inflammation","volume":"130","author":"Day","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.11.033_bib45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.dld.2015.10.003","article-title":"Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children","volume":"48","author":"Mancina","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.11.033_bib47","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.12840","article-title":"Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients","volume":"35","author":"Bril","year":"2015","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/gastro\/gox012","article-title":"Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy","volume":"5","author":"Procopet","year":"2017","journal-title":"Gastroenterol. Rep. (Oxf)."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.11.033_bib49","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2016.01.005","article-title":"Hepatic transmembrane 6 superfamily member 2 regulates cholesterol metabolism in mice","volume":"150","author":"Fan","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.plipres.2005.09.002","article-title":"The metabolism of structured triacylglycerols","volume":"44","author":"Mu","year":"2005","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.11.033_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/nu9040349","article-title":"Role of the enterocyte in fructose-induced hypertriglyceridaemia","volume":"9","author":"Steenson","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","article-title":"Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids","volume":"5","author":"Ferrebee","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.033_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/apt.14154","article-title":"Editorial: new insights into the relationship between the intestine and non-alcoholic fatty liver-is \"fatty gut\" involved in disease progression?","volume":"46","author":"Valenti","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/jpet.114.216796","article-title":"Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum","volume":"351","author":"Cheng","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.033_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/joim.12140","article-title":"Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism","volume":"275","author":"Hu","year":"2014","journal-title":"J.\u00a0Intern Med."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.11.033_bib56","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/17474124.2015.1056156","article-title":"Physiology and pathophysiology of liver lipid metabolism","volume":"9","author":"Ponziani","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.11.033_bib57","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1021\/jm800965b","article-title":"Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity","volume":"51","author":"Berardi","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"3\u20135","key":"10.1016\/j.atherosclerosis.2017.11.033_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2007.03.001","article-title":"Functional analysis of cholesterol biosynthesis by RNA interference","volume":"104","author":"Guggenberger","year":"2007","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.11.033_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.plipres.2016.09.003","article-title":"DHCR7: a vital enzyme switch between cholesterol and vitamin D production","volume":"64","author":"Prabhu","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2017.11.033_bib60","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1074\/jbc.M115.699546","article-title":"Cholesterol-mediated degradation of 7-dehydrocholesterol reductase switches the balance from cholesterol to vitamin D synthesis","volume":"291","author":"Prabhu","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.11.033_bib61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2013.11.010","article-title":"ABCG5\/ABCG8 in cholesterol excretion and atherosclerosis","volume":"428","author":"Yu","year":"2014","journal-title":"Clin. Chim. Acta."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mnfr.201000161","article-title":"Dietary calcium decreases plasma cholesterol by down-regulation of intestinal Niemann-Pick C1 like 1 and microsomal triacylglycerol transport protein and up-regulation of CYP7A1 and ABCG 5\/8 in hamsters","volume":"55","author":"Ma","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"7604","key":"10.1016\/j.atherosclerosis.2017.11.033_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature17666","article-title":"Crystal structure of the human sterol transporter ABCG5\/ABCG8","volume":"533","author":"Lee","year":"2016","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2017.11.033_bib64","doi-asserted-by":"crossref","first-page":"16237","DOI":"10.1073\/pnas.252582399","article-title":"Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion","volume":"99","author":"Yu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.033_bib65","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbalip.2017.02.014","article-title":"Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat","volume":"1862","author":"Hung","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.11.033_bib66","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1021\/acs.jmedchem.7b00173","article-title":"Discovery of an orally bioavailable benzimidazole diacylglycerol acyltransferase 1 (DGAT1) inhibitor that suppresses body weight gain in diet-induced obese dogs and postprandial triglycerides in humans","volume":"60","author":"Nakajima","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.033_bib67","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jcp.25954","article-title":"Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells","volume":"233","author":"Xu","year":"2018","journal-title":"J.\u00a0Cell Physiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.11.033_bib68","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1194\/jlr.P076034","article-title":"Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns","volume":"58","author":"Kim","year":"2017","journal-title":"J.\u00a0Lipid Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T08:37:56Z","timestamp":1565339876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017314181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":68,"alternative-id":["S0021915017314181"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.033","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TM6SF2: A novel target for plasma lipid regulation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}